Thierry Piéton
Executive Vice President and Chief Financial OfficerMedtronic
Medical DevicesView Profile →Chief Financial Officer, Secretary and Director · Somero Enterprises
Chief Financial Officer, Secretary and a director of Somero Enterprises, the AIM-listed Fort Myers, Florida maker of Laser Screed concrete-placing machinery, which he joined in September 2018 as Vice President of Finance and Controller. Known as Enzo, he was previously Vice President of Finance at Conformis and Chief Financial Officer of the SEC-reporting medical device company Cambridge Heart.
Last reviewed: Sep 28, 2026
Chief Financial Officer, Secretary and Director Somero Enterprises
Last Reviewed: September 28, 2026
Vincenzo “Enzo” LiCausi is Chief Financial Officer, Secretary and a director of Somero Enterprises, the Fort Myers, Florida manufacturer of Laser Screed machines that spread and level concrete for commercial floors. Its shares trade on London’s AIM market. He joined Somero in September 2018 as Vice President of Finance and Controller. He is a finance executive trained in public accounting and has spent most of his career in U.S. public-company finance. Before Somero he was Vice President of Finance at the orthopaedics company Conformis. Before that he was Chief Financial Officer of the SEC-reporting cardiac diagnostics company Cambridge Heart, whose periodic reports he signed as principal financial and accounting officer. Somero’s September 2026 board refresh left five non-executive and two executive directors. He remains on the board and presented the company’s 2026 half-year results with the CEO.
LiCausi began his career in 1997 at Deloitte & Touche in Boston and became a Senior Auditor there. In 2001 he moved into corporate finance as Senior Financial Analyst of Planning & Analysis at Tropicana Products, then a division of PepsiCo. From 2004 to 2006 he worked at Bard Electrophysiology, a division of C.R. Bard, in several positions including General Accounting Manager.
In October 2006 he joined Cambridge Heart, a Massachusetts company that sold equipment for Microvolt T-Wave Alternans testing, a non-invasive cardiac risk test. He started as Controller and was made Chief Financial Officer and Vice President of Finance and Administration in July 2007, at 34. Cambridge Heart was a small SEC registrant. As CFO he also served as Treasurer and Corporate Secretary, signed its annual reports as principal financial and accounting officer, and gave the financial review on its earnings calls. The company’s filings name him through at least late 2012.
Somero’s biography of him also lists senior financial roles at Gillette; those dates are not established. He then became Vice President of Finance at Conformis, described in Somero’s biography of him as a NASDAQ-listed orthopaedics manufacturer and marketer. A Conformis equity distribution agreement dated May 2017 names him in that role as one of the company’s authorized representatives.
He joined Somero Enterprises in September 2018 as Vice President of Finance and Controller. Somero makes laser-guided screeds and material placement machines for commercial concrete construction. It has its headquarters in Fort Myers, Florida and also operates in Michigan. He went on to become Chief Financial Officer, Corporate Secretary and a director; when he took the CFO title is not documented in the sources read. Tim Averkamp became Chief Executive Officer in April 2025. In 2026 Somero reviewed its governance after several resolutions failed at its June AGM, expanded its share buyback programme, and refreshed its board. On 21 September 2026 it appointed two new non-executive directors, one of them under a stockholder agreement with a group holding about 44% of the shares, and left the board with five non-executive and two executive directors. LiCausi remains on the board and is named as CFO in the company’s announcements.
Bentley College (now Bentley University)
B.S., Accountancy